+ 7 (495) 684-04-00

Back to Science

We review a name we had good luck with last year. As medtech has gone nowhere with the Delta variant keeping elective procedures to a minimum, company management feels things are changing for the better.
To access this post, you must purchase Subscription Plan – AVC Pro.

Subscribe

Scroll to Top